m 8218 has been researched along with fibrinogen in 1 studies
| Studies (m 8218) | Trials (m 8218) | Recent Studies (post-2010) (m 8218) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 118 | 24 | 80 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Tan, HB; Zhao, Q | 1 |
1 other study(ies) available for m 8218 and fibrinogen
| Article | Year |
|---|---|
Penehyclidine hydrochloride suppresses inflammation response and reduces podocyte injury in diabetic nephropathy by targeting fibrinogen-like protein 2.
Topics: Animals; Caspase 1; Diabetes Mellitus; Diabetic Nephropathies; Female; Fibrinogen; Humans; Inflammation; Male; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Podocytes; Quinuclidines; Rats; Toll-Like Receptor 4 | 2022 |